In the BioHarmony Drug Report Database
Xyzal, Xyzal 24hr (levocetirizine) is a small molecule pharmaceutical. Levocetirizine was first approved as Xyzal on 2007-05-25. It is used to treat allergic rhinitis perennial, allergic rhinitis seasonal, and urticaria in the USA. The pharmaceutical is active against histamine H1 receptor. In addition, it is known to target albumin. Levocetirizine dihydrochloride’s patent is valid until 2027-10-16 (FDA).
Image (chem structure or protein)